[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
December 2006

Screening for Retinopathy of PrematurityThe Promise of New Approaches

Arch Ophthalmol. 2006;124(12):1775-1776. doi:10.1001/archopht.124.12.1775

Timely recognition and treatment of retinopathy of prematurity (ROP) is the cornerstone to improving chances for preserving vision in premature infants. The window of time when treatment must be offered is short, sometimes lasting only a few days, but the window is often predictable. Onset and evolution of ROP is timed more to the gestational age than the chronological age of premature infants. The median age when infants could develop stage 3 disease, for example, is 36.6 weeks.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×